This site is intended for healthcare professionals seeking information on the CMS/HRSA sponsored End Stage Renal Disease Treatment Choices Learning Collaborative. If you are a patient seeking information on Kidney Transplants click HERE
Center
In July 2019, an Executive Order was signed to launch the Advancing American Kidney Health (AAKH) initiative to transform the way we prevent and treat kidney disease. To accomplish the goals of the AAKH initiative, the Centers for Medicare & Medicaid Services (CMS) created the End Stage Renal Disease (ESRD) Treatment Choice (ETC) payment models to encourage preventative kidney care, home dialysis and kidney transplants.
To support the ETC model’s focus on increased kidney transplants, CMS, in collaboration with the Health Resources & Services Administration (HRSA), has established the ESRD Treatment Choice Learning Collaborative (ETCLC). The ETCLC will bring Transplant Centers, Organ Procurement Organizations (OPO), donor hospitals, patients and families together to generate increase quality and cost savings to CMS using systematic quality and process improvement methods.
This work will be supported by a National Faculty and Leadership Coordinating Council made up of more than twenty organizations in the field. You can learn more about these groups by scrolling below.
National Faculty provide subject matter expertise to advise ETCLC participants throughout the improvement process. Led by two National Chairpersons, the eleven national faculty represent transplant nephrologists and surgeons, Organ Procurement Organization professionals, donor hospitals, data analysts and statisticians, and patients.
The Leadership Coordinating Council is a group of 20 national stakeholders that guide the ETCLC. Members represent the kidney community, hospitals, dialysis services, quality improvement, social work, and patients.